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Regeneration of alveolar bone is critical for the successful treatment of periodontal diseases. The periodontal 
ligament (PDL) has been widely investigated as a source of cells for the regeneration of periodontal tissues. 
In the present study where we attempted to develop an effective strategy for alveolar bone regeneration, we 
examined the osteogenic potential of side population (SP) cells, a stem cell-containing population that has been 
shown to be highly abundant in several kinds of tissues, in PDL cells. Isolated SP cells from the rat PDL exhib-
ited a superior ability to differentiate into osteoblastic cells compared with non-SP (NSP) and unsorted PDL 
cells in vitro. The mRNA expressions of osteoblast markers and bone morphogenetic protein (BMP) 2 were 
significantly upregulated in SP cells and were further increased by osteogenic induction. To examine the bone-
forming activity of SP cells in vivo, PDL SP cells isolated from green fluorescent protein (GFP)-transgenic rats 
were transplanted with hydroxyapatite (HA) disks into wild-type animals. SP cells exhibited a high ability to 
induce the mineralized matrix compared with NSP and unsorted PDL cells. At 12 weeks after the implantation, 
some of the pores in the HA disks with SP cells were filled with mineralized matrices, which were positive 
for bone matrix proteins, such as osteopontin, bone sialoprotein, and osteocalcin. Furthermore, osteoblast- and 
osteocyte-like cells on and in the bone-like mineralized matrices were GFP positive, suggesting that the matri-
ces were directly formed by the transplanted cells. These results suggest that PDL SP cells possess enhanced 
osteogenic potential and could be a potential source for cell-based regenerative therapy for alveolar bone.
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INTRODUCTION
A sufficient amount of regeneration of alveolar bone is 
essential for the successful treatment of periodontal dis-
eases and dental implants. To achieve better therapeutic 
results, several kinds of methods using various materi-
als and techniques have been investigated. Among these 
trials, cell-based therapies, especially those using mes-
enchymal stem cells (MSCs), have generally produced 
acceptable results (1,6,19,20).
Since alveolar bone is originally formed by osteoblasts 
that had differentiated from periodontal ligament (PDL) 
cells, the PDL has been considered to be a potential source 
for cell-based regenerative therapy. In support of this 
notion, previous reports, including ours, showed that PDL 
cells have osteogenic potential (10,26). These observa-
tions, together with the results obtained with MSCs, led 
us to hypothesize that the stem cell population of PDL 
cells may have a higher ability to regenerate alveolar bone 
than other cells in the PDL population.
Efficient identification and isolation of an appropri-
ate stem cell population are critical processes to develop 
stem cell-based regenerative therapies. The stem cells in 
the PDL have been identified by the detection of cell sur-
face antigens, such as STRO-1, cluster of differentiation 
44 (CD44), CD106, and CD146 (5,17), all of which are 
also used as markers of bone marrow-derived MSCs. The 
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PDL stem cells showed the ability to differentiate into 
multiple cell types, including osteoblastic, adipocytic, 
and chondrocytic cells in vitro (29), and repaired peri-
odontal defects by forming cementum-like and PDL-like 
periodontal tissue in vivo (26).
As an alternative method for isolating PDL stem cells, 
in the present study, we focused on side population (SP) 
cells. SP cells appear as a tail of dimly stained cells when 
PDL cells are stained with Hoechst 33342, a DNA-binding 
fluorescence dye, and examined by dual-wavelength flow 
cytometry (7). SP cells have been found in several kinds 
of tissues, including bone marrow and dental pulp (7,15), 
and shown to be highly enriched in stem cells. Although SP 
cells were also identified in the PDL (18), their ability to 
regenerate periodontal tissues remains to be elucidated.
To explore this issue, we isolated SP cells from rat 
PDL cells by using a fluorescence-activated cell sorter 
(FACS) system and examined their osteogenic potential 
in vitro and in vivo.
MATERIALS AND METHODS
Reagents
Rabbit polyclonal antibody against bone sialoprotein 
(BSP) was purchased from Alexis Corp. (Lausen, Switzer-
land), and that specific for osteopontin (OPN) was described 
previously (22). Goat polyclonal antibody against osteo-
calcin (OCN) was from Biomedical Technologies, Inc. 
(Stoughton, MA, USA). All other materials used in this 
study were purchased from Sigma-Aldrich (St. Louis, MO, 
USA) or Wako Pure Chemical Industries, Ltd. (Osaka, 
Japan) unless otherwise specified.
Isolation of Rat PDL Cells
Rat PDL cells were isolated from 10 green fluorescent 
protein (GFP)-transgenic male rats (5 weeks old, Lewis 
strain) (8,13) as previously described (10). These rats 
were generously provided by PhoenixBio Co. (Tochigi, 
Japan). Litters of mutant rats were produced and raised in 
our animal facility. Before SP cell isolation, the PDL cells 
were cultured for 6 days in growth medium, a-minimum 
essential medium (aMEM, Sigma-Aldrich) supplemented 
with 10% fetal bovine serum (FBS, Biological Industries 
Ltd., Haemek, Israel) and antibiotic–antimycotic (Life 
Technologies Japan Ltd., Tokyo, Japan), in a humidified 
atmosphere of 5% CO2 in air. All animal experiments 
were reviewed and approved by the Animal Management 
Committee of Matsumoto Dental University.
Identification and Isolation of SP Cells
Harvested PDL cells suspended at 1 × 106 cells/ml 
in Hanks’ balanced salt solution (HBSS, Life Technol-
ogies Japan Ltd.) supplemented with 10 mM 2-[4-(2- 
hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES) 
and 2% FBS were incubated with 5 mg/ml Hoechst 33342 
dye (Sigma-Aldrich) for 60 min at 37°C. Some cells were 
incubated in the presence of 50 mM verapamil (Sigma-
Aldrich), an inhibitor of the ATP-binding cassette (ABC) 
transporter, especially P-glycoprotein/multidrug resis-
tance 1 (MDR-1) (28). The cells were then washed with 
HBSS, analyzed, and sorted by the use of a FACS Vantage 
SE (BD Biosciences, San Jose, CA, USA). Cells in the 
typical main population and those in the population that 
disappeared in the presence of verapamil were isolated as 
non-SP (NSP) and SP cells, respectively.
Cell Proliferation
SP and NSP cells (5 × 102 cells/well) were plated in 
96-well plates (BD Biosciences, Tokyo, Japan) and cultured 
for 24 h in growth medium. Cell proliferation was deter-
mined for the subsequent 6 days by using a nontoxic col-
orimetric-based Alamar blue assay (Biosource, Camarillo, 
CA, USA) according to the manufacturer’s protocol.
Osteoblastic, Adipocytic, and Chondrocytic 
Differentiation In Vitro
Osteoblastic differentiation was determined as described 
previously (23). SP, NSP, and unsorted PDL cells were 
cultured with or without osteogenic induction for 5 or 
10 days. Alkaline phosphatase (ALPase) activity and 
alizarin red staining were performed as described previ-
ously (16,23). To test the effects of Hoechst 33342 on 
osteoblast differentiation, unsorted PDL cells pretreated 
with Hoechst 33342 (5 mg/ml) for 60 min at 37°C were 
cultured for 7 or 21 days. Adipocytic differentiation was 
determined as described previously (24). The cells were 
cultured for 21 days and then stained with Oil Red O 
solution. Chondrocytic differentiation was determined 
as described previously (30). The cells were cultured for 
14 days and stained with Alcian blue.
Microarray Analysis
Total RNA was extracted by using an RNeasy Plus 
Micro Kit (QIAGEN, Tokyo, Japan) and reverse tran-
scribed with oligo(dT) primer containing the T7 promoter. 
Cy3- or Cy5-labeled cRNA was synthesized from a cDNA 
pool and purified with an RNeasy Mini Kit (QIAGEN). 
Labeled cRNA was then fragmented and hybridized to 
the microarray of a Whole Rat Genome Microarray Kit 
(Agilent Technologies, Inc., Santa Clara, CA, USA) at 
65°C overnight. A color-swap experiment was performed 
for the dye-specific effect and to ensure statistically rel-
evant data. Hybridized microarray slides were scanned 
with an Agilent DNA Microarray Scanner (Agilent 
Technologies) at 5-mm resolution. The scanned images 
were analyzed numerically by using Agilent Feature 
Extraction Software (G256AA, Agilent Technologies).
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Reverse Transcriptase Polymerase Chain 
Reaction (RT-PCR)
Total RNA was isolated with the RNeasy Plus Micro 
Kit. The cDNA was synthesized by using PrimeScript 
Reverse Transcriptase (Takara Bio Inc., Shiga, Japan). 
The sequences of primers were as follows: mdr-1, 5¢-att 
tggcaaagctggagaga-3¢ (forward) and 5¢-accctgtagcccctttc 
act-3¢ (reverse); glyceraldehyde-3-phosphate dehydroge-
nase (gapdh), 5¢-atgggaagctggtcatcaac-3¢ (forward) and 
5¢-gtggttcacacccatcacaa-3¢ (reverse). PCR products were 
separated on 2% agarose gels containing ethidium bro-
mide and visualized under ultraviolet light. The size of 
the fragments was confirmed by reference to a 100-bp 
DNA ladder.
Real-Time RT-PCR
SP and NSP cells (1 × 105 cells/well) were plated in 
six-well plates (BD Biosciences, Japan) and cultured with 
or without osteogenic induction for 5 days or with adipo-
genic induction as described above for 21 days. Real-
time RT-PCR was performed by using One Step SYBR 
PrimeScript PLUS RT-PCR Kit (Takara Bio) and a 
StepOnePlus Real-time PCR system (Applied Biosystems, 
Tokyo, Japan) according to the manufacturer’s protocol. The 
sequences of primers were as follows: tissue-nonspecific 
alkaline phosphatase (tnap), 5¢-gcacaacatcaaggacatcg-3¢ 
(forward) and 5¢-tcagttctgttcttggggtacat-3¢ (reverse); osterix 
(osx), 5¢-ctgcacccccagaaaaag-3¢ (forward) and 5¢-cagatct 
ctagcaggttgctctg-3¢ (reverse); runt-related transcription 
factor 2 (runx2), 5¢-cgtacccaggcgtatttcag-3¢ (forward) 
and 5¢-tgcctggctcttcttactgag-3¢ (reverse); bsp, 5¢-tcggaa 
gaaaatggagatgg-3¢ (forward) and 5¢-ttcctcttcatttgaagtctc 
ctc-3¢ (reverse); ocn, 5¢-atagactccggcgctacctc-3¢ (forward) 
and 5¢-ccaggggatctgggtagg-3¢ (reverse); opn, 5¢-cggtgaaag 
tggctgagttt-3¢ (forward) and 5¢-ggctacagcatctgagtgtttg-3¢ 
(reverse); bone morphogenetic protein 2 (bmp2), 5¢-cgg 
actgcggtctcctaa-3¢ (forward) and 5¢-ggggaagcagcaacact 
aga-3¢ (reverse); perox isome proliferator-activated recep- 
tor g (pparg), 5¢-ccctggcaaagcatttgtat-3¢ (forward) and 5¢-ac 
tggcacccttgaaaaatg-3¢ (reverse); lipoprotein lipase (lpl), 
5¢-cagagaaggggcttggaga-3¢ (forward) and 5¢-ttcattcagc 
agggagtcaa-3¢ (reverse); b-actin, 5¢-cccgcgagtacaacct 
tct-3¢ (forward) and 5¢-cgtcatccatggcgaact-3¢ (reverse). 
Values of mRNA were determined using an appropriate 
standard curve and were normalized with those of the 
internal control, b-actin. All assays were performed in 
triplicate.
BMP2 ELISA
SP and NSP cells (2 × 104 cells/dish) were plated in 
35-mm dishes (BD Biosciences, Japan) and cultured in 
serum-free growth medium for 24 h. The BMP2 level 
in the culture supernatant was measured by the use of 
a BMP2 Quantikine ELISA Kit (R & D Systems, Inc., 
Minneapolis, MN, USA) according to the manufacturer’s 
protocol.
Cell Transplantation
SP, NSP, and unsorted PDL cells (5 × 105 cells/
disk) were plated on five hydroxyapatite (HA) disks 
(CELLYARD HA scaffold, f5 × 2 mm, 50% porosity, 
Pentax Corp., Tokyo, Japan) and then cultured in growth 
medium for 24 h. After having been rinsed with PBS, the 
disks were transplanted bilaterally under the fascia of the 
dorsal muscles of 6-week-old male wild-type Lewis rats 
(SLC Japan Co., Ltd., Shizuoka, Japan) under anesthesia 
with pentobarbital (0.05 mg/g body weight, IP; Dainippon 
Sumitomo Pharma Co., Ltd., Osaka, Japan).
Histological Analysis
Unfixed, Frozen, and Nondecalcified Sections. After 
the rats had been sacrificed by an overdose of diethyl 
ether, the implanted HA disks and their surrounding tis-
sues were dissected en bloc, embedded in 5% carboxy-
methyl cellulose gel, and immediately frozen in hexane at 
−80°C (11). Then, sections were made with a cryomicro-
tome (CM3050; Leica Microsystems K.K., Tokyo, Japan) 
and stained with 0.05% toluidine blue (pH 7.0) or 1% 
alizarin red S. GFP-positive cells were observed with a 
fluorescence microscope. The numbers of total pores in 
the disks, of pores with GFP-positive cells, and of pores 
with mineralized matrix were counted by examining 
seven randomized sections from each specimen. Total 
areas of GFP-positive pores and a mineralized matrix 
with osteocyte-like cells were measured by using analytic 
software (TRI/2D-BON, Ratoc System Engineering Co., 
Ltd., Tokyo, Japan).
Decalcified Paraffin Sections. Under anesthesia with 
pentobarbital (0.05 mg/g body weight), the rats were 
perfused through their left ventricle with 4% paraform-
aldehyde solution. The HA disks and surrounding tissues 
were dissected en bloc, immersed in the same fixative 
overnight, decalcified in 10% EDTA solution for 8 weeks 
at 4°C, and embedded in paraffin. Paraffin sections were 
made according to the conventional methods (31).
Immunohistochemistry. Immunohistochemical staining 
of BSP, OPN, and OCN was performed by using a Histofine 
Simple Stain Kit (Nichirei Biosciences Inc., Tokyo, Japan) 
according to the manufacturer’s protocol. Chromogen was 
developed by the use of a diaminobenzidine (DAB) Liquid 
System (Dako Japan Inc., Kyoto, Japan). The slides were 
counter stained with hematoxylin.
Enzyme Histochemistry. ALPase was detected as 
described previously (16).
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Figure 1. Identification and isolation of SP cells from rat PDL. (A, B) Representative dot plots of Hoechst 33342-stained periodontal 
ligament (PDL) cells in the absence (A) and presence (B) of verapamil. Side population (SP) and non-SP (NSP) cells in the gated regions 
were isolated and used for the experiments. Hoechst 33342 fluorescence is displayed at two emission wavelengths (red and blue) with 
ultraviolet (UV) excitation. (C) Cell proliferation examined by performing the Alamar blue assay (n = 3). The data are presented as the 
mean ± SD. *p < 0.01 compared with OD value for NSP cells. (D) Microarray analysis of the expression of ATP-binding cassette (ABC) 
transporter family members in SP and NSP cells. The data are expressed as fold increase compared with values for NSP. (E) RT-PCR 
analysis of multidrug resistance 1 (mdr-1) mRNA expression. Glyceraldehyde 3-phosphate dehydrogenase (gapdh) served as a control. 
(F) Microarray analysis of the expression of mesenchymal stem cell (MSC) markers in SP and NSP cells. The data are expressed as fold 
increase compared with values for NSP. Microarray analysis was performed twice. cd44: cluster of differentiation 44.
FACING PAGE
Figure 2. Osteoblastic differentiation of SP cells. (A) Alkaline phosphatase (ALPase) and alizarin red staining of SP, NSP, and 
unsorted PDL cells cultured for 5 or 10 days with or without osteogenic induction. (B) Real-time RT-PCR analysis of mRNA expres-
sion of osteoblast markers tissue-nonspecific alkaline phosphatase (tnap), osterix (osx), runt-related transcription factor 2 (runx2), 
bone sialoprotein (bsp), osteocalcin (ocn), and osteopontin (opn). SP and NSP cells were plated in six-well plates and cultured for 0 
or 5 days with or without osteogenic induction (each n = 3). (C) Microarray analysis of the expression of bone morphogenetic protein 
(BMP) family members in SP and NSP cells. The data are expressed as fold increase compared with values for NSP. Microarray 
analysis was performed twice. (D) Real-time RT-PCR analysis of bmp2 mRNA expression. SP and NSP cells were plated in six-well 
plates and cultured for 0 or 5 days with or without osteogenic induction (n = 3). (E) BMP2 production by SP and NSP cells determined 
by ELISA (n = 3). The cells were cultured for 24 h, and the culture supernatant was then collected. In the various graphs, the data are 
presented as the mean ± SD. *p < 0.01 versus NSP cells on day 0, †p < 0.01 versus either cell population on day 0, ‡p < 0.01 versus either 
cell population without osteogenic induction on day 5, §p < 0.01 versus value for NSP cells.
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Statistical Analysis
Data were expressed as the mean and standard devia-
tion (SD) for each group. Comparisons between SP, NSP, 
and unsorted PDL cell groups were performed by one-way 
analysis of variance (ANOVA) and the post hoc Tukey 
test. Values of p < 0.05 were considered significant.
RESULTS
Identification and Isolation of SP Cells From 
Rat PDL Cells
Flow cytometric analysis identified SP cells in the rat 
PDL cell population, in which cells comprised 2.6 ± 0.9% 
of the total PDL cells (Fig. 1A). The cells in this SP frac-
tion disappeared in the presence of verapamil, an inhibi-
tor of MDR-1 (Fig. 1B) (9). The in vitro cell proliferation 
of isolated SP cells, as determined by performing the 
Alamar blue assay, was significantly lower than that of 
the NSP cells (Fig. 1C). Microarray analysis showed that 
the mRNA expression of ABC transporters other than 
mdr-1 was similar between SP and NSP cells and revealed 
that SP cells mainly efflux Hoechst dye by MDR-1 trans-
porter (Fig. 1D). Semiquantitative RT-PCR analysis dem-
onstrated that the mRNA expression of mdr-1 in SP cells 
was higher than that in NSP cells (Fig. 1E). Microarray 
data showed that several markers of MSCs, such as cd44, 
cd90, cd105, and cd166, were upregulated in SP cells 
compared with their expression in NSP cells (Fig. 1F).
Abilities of SP Cells in Osteoblastic Differentiation 
and Calcification
SP cells expressed higher ALPase activity than did 
NSP cells at the basal level (Fig. 2A). Real-time RT-PCR 
analysis showed that mRNA expression of tnap and osx at 
day 0 was significantly upregulated in SP cells (Fig. 2B). 
SP cell cultures in osteogenic medium showed markedly 
increased ALPase activity and formation of a mineralized 
matrix, whereas these changes were not seen in the NSP 
cells (Fig. 2A). The ALPase activity of unsorted PDL cells 
at day 5 was slightly higher than that of NSP cells, but 
much lower than that of SP cells, in either growth medium 
or osteogenic induction medium (Fig. 2A). Mineralized 
matrix formation was not observed in unsorted PDL 
cells at day 10 (Fig. 2A). The expression of all osteoblast 
markers examined, that is, tnap, osx, runx2, bsp, ocn, and 
opn, was increased in SP cells by the osteogenic induc-
tion (Fig. 2B). Of interest, the mRNA expression of tnap, 
osx, and runx2 in SP cells was elevated during culture 
even without the induction. Such upregulation in NSP 
cells was rarely observed (Fig. 2B).
Expression of BMPs in SP Cells
From microarray analysis, we found that BMP2 
expression was upregulated in SP cells (Fig. 2C). BMP 
expression in SP and NSP cells was also confirmed by real-
time RT-PCR (Fig. 2D). Steady-state secretion of BMP2 
into the culture medium was also increased in the SP cells 
(Fig. 2E). Furthermore, mRNA expression of BMP2 in 
SP cells was spontaneously increased during culture and 
became more efficient with osteogenic induction (Fig. 
2D). On the other hand, expression of BMP receptors and 
BMP2-induced intracellular signaling determined by the 
phosphorylation of small body size/mothers against deca-
pentaplegic 1/5/8 (Smad1/5/8) was not different between 
SP and NSP cells (data not shown).
Multipotency of SP Cells
Since PDL cells have been shown to contain multi-
potent cells that have the ability to differentiate into 
multiple kinds of mesenchymal lineage cells, including 
osteoblasts and adipocytes (10), we examined whether 
PDL SP cells possessed these capacities. A small popula-
tion of SP and NSP cells exhibited adipocytic differentia-
tion when cultured for 21 days in the induction medium 
(Fig. 3A). Although the expressions of adipocyte mark-
ers, such as pparg and lpl, in SP cells were upregulated 
by adipogenic induction, they were lower than those in 
NSP cells (Fig. 3B). Chondrocytic differentiation was not 
induced in either cell population (data not shown).
Figure 3. Adipogenic differentiation of SP cells. (A) Oil red 
O staining of SP and NSP cells cultured for 21 days with adi-
pogenic induction. Arrow shows an adipocyte. (B) Real-time 
RT-PCR analysis of mRNA expression of adipocyte markers 
peroxisome proliferator-activated receptor g (pparg) and lipo-
protein lipase (lpl). SP and NSP cells were plated in six-well 
plates and cultured for 0 or 21 days with adipogenic induction 
(each n = 3). The data are presented as the mean ± SD. *p < 0.01 
versus NSP cells on day 21.
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Effects of Hoechst 33342 on Proliferation and 
Differentiation of PDL Cells
It has been argued that the phenotypic differences 
between SP and NSP cells are a consequence of damage 
induced by Hoechst 33342, which is retained longer in 
NSP cells (7). To exclude this possibility, we tested the 
effects of the Hoechst dye on proliferation and osteoblast 
differentiation of unsorted PDL cells. The dye at a con-
centration employed for the detection of SP (5 mg/ml) did 
not affect the proliferation, differentiation, or mineraliza-
tion of the PDL cells (Fig. 4), suggesting that the differ-
ences between SP and NSP cells were not attributable to 
the pharmacological effects of the Hoechst dye.
Formation of Mineralized Matrix by SP Cells In Vivo
To determine whether SP cells possessed the ability to 
form a bone-like matrix in vivo, we plated SP and NSP 
cells isolated from GFP-transgenic rats on HA disks and 
transplanted them into wild-type rats of the same strain 
(Fig. 5). At 4 weeks after the implantation, the pores in 
the HA disks were filled with GFP-positive PDL cells 
(Fig. 5A, C, D, F, G, I). Alizarin red staining showed 
mineralized matrix formation on the surface of the pores 
in the SP cell and PDL cell-seeded HA (SP-HA and 
PDL-HA, respectively) disks (Fig. 5B, H), the forma-
tion of which was not observed in the NSP cell-seeded 
HA (NSP-HA) disks (Fig. 5E). At 12 weeks, some of 
the pores in the SP- and PDL-HA disks were filled with 
an alizarin red-positive matrix (Fig. 5K, Q). The matrix 
formation was found in approximately 33% and 12% 
of the pores with SP and unsorted PDL cell infiltration, 
respectively, whereas no matrix formation was seen in 
the pores containing NSP cells (Fig. 5T). Likewise, SP 
cells induced a large amount of mineralized matrix com-
pared with other cells (Fig. 5U). The ratio of cell infil-
tration into the pores was approximately 30% in each 
disk (Fig. 5S). Fluorescence microscopic observations 
showed that the matrix-embedded osteocyte-like cells 
were GFP positive (Fig. 5R). Immunohistochemical 
examination demonstrated that the matrices formed in 
the SP-HA disks were positive for bone matrix proteins, 
such as OPN, BSP, and OCN (Fig. 6B–D). ALPase-
positive osteoblast-like cells were also seen on the 
formed matrices (Fig. 6E).
DISCUSSION
SP cells possess an efflux function of drug or dye via 
ABC transporters. The ABCG2/ breast cancer resistance 
protein 1 (BCRP1) transporter is especially expressed in 
SP cells of several tissues and is considered as a general 
stem cell marker (3,32). We determined the expressions 
of abc transporters in SP and NSP cells. However, there 
was not much difference between the abcg2 expressions 
in these cells. On the other hand, the abcb1/mdr-1 expres-
sion in SP cells was approximately sixfold higher level 
than that in NSP cells. In the flow cytometric analysis, 
the cells in the SP fraction disappeared in the presence 
of verapamil, an inhibitor of MDR-1. These findings 
revealed that verapamil is suitable for detection of SP 
fraction in PDL cells.
Several lines of evidence suggest that PDL cells have an 
osteoblast-like phenotype and osteogenic potential in vitro 
and in vivo (10,12). However, since PDL cells consist of 
 heterogeneous cell populations, including mature fibro-
blasts and the precursor cells that can differentiate into 
fibroblasts, cementoblasts, and osteoblasts, which kind of 
cells are directly responsible for the osteoblastic phenotype 
of PDL cells must be determined. Establishment of meth-
ods to efficiently identify osteogenic cells is also important 
for potential clinical applications of PDL cells for regen-
erative therapy of alveolar bone. In the present study, we 
showed for the first time that rat PDL SP cells possessed 
a strong ability to differentiate into osteoblast-like cells in 
vitro and to form a bone-like mineralized matrix in vivo.
Figure 4. Effects of Hoechst 33342 on proliferation and osteoblast differentiation of PDL cells. (A) Unsorted PDL cells with or 
without treatment of Hoechst 33342 (5 mg/ml) were cultured in growth medium. Cell proliferation was determined by performing 
the Alamar blue assay. (B) Treated and nontreated PDL cells were cultured with osteogenic induction. Osteoblast differentiation was 
determined by ALPase and alizarin red staining at days 7 and 21, respectively (each n = 3).
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It is of particular note that our in vitro and in vivo stud-
ies demonstrated that the abilities of PDL SP cells to dif-
ferentiate into osteoblastic cells and to induce a bone-like 
mineralized matrix was superior not only to that of NSP 
cells but also to that of unsorted PDL cells. These findings 
prove our hypothesis that this predifferentiated population 
of PDL cells has the greater ability to regenerate bone.
Our results showed that PDL SP cells expressed higher 
baseline levels of tnap and osx mRNAs and ALPase 
activity than NSP cells and that these levels were further 
increased by the osteogenic induction. The other osteo-
blast differentiation markers, runx2, bsp, ocn, and opn, 
were also markedly upregulated in SP cells by the induc-
tion. Of interest, SP cells showed a spontaneous increase 
in the mRNA expression of these genes during culture. 
These results suggest the possibility that the population 
of SP cells contains a substantial subpopulation of cells 
that are committed to the osteoblast lineage.
Microarray analysis revealed that steady-state bmp2 
expression was elevated in SP cells, a finding that was 
confirmed by real-time RT-PCR and ELISA. However, 
the expressions of BMP receptors and the intracellular sig-
nals in response to BMP2 were not different between SP 
and NSP cells. Therefore, in addition to the differences in 
intrinsic properties, the autocrine actions of this increased 
amount of BMP2 may also account for the spontaneous 
differentiation of PDL SP cells into osteoblastic cells in 
vitro. It is also possible that these effects beneficially 
affect bone formation in vivo.
Since their original discovery (7), SP cells have been 
identified in a variety of tissues and recognized as a stem 
cell-enriched population (4). Consistent with this notion, 
microarray analysis showed the higher expression of 
MSC markers (2,17), including cd44, cd90, cd105, and 
cd166, in PDL SP cells. However, although PDL SP cells 
exhibited multipotency to differentiate into osteoblastic 
and adipocytic cells, the ability to differentiate into adi-
pocytes was lower than that of the NSP cells. These data 
suggest that PDL SP cells possess some of the MSC-like 
phenotypes but do not completely maintain the MSC-like 
undifferentiated state. The results also suggest that PDL 
SP cells are not identical to the previously described PDL 
stem cells (17,26,29).
Immunohistochemical analysis demonstrated that the 
mineralized matrix formed in the SP-HA disks was posi-
tive for bone matrix proteins, that is, OPN, BSP, and OCN. 
These results indicate that the matrix was bone-like in 
nature. In addition, fluorescence microscopic observations 
FACING PAGE
Figure 5. Histological analysis of the mineralized matrix formation. Histological analysis of the mineralized matrix formation in 
unsorted PDL- (A–C, J–L), NSP- (D–F, M–O), and SP-hydroxyapatite (HA) disks (G–I, P–R) at 4 (A–I) and 12 (J–R) weeks after the 
implantation using undecalcified frozen sections. Dotted lines in the green fluorescent protein (GFP) images (C, F, I, L, O, R) indicate 
the border between pore and HA disks (scale bar: 100 mm). Ratio of GFP-positive pores to total pores (S), of pores with bone-like 
matrix (BLM) to GFP-positive pores (T), and of total BLM area to GFP-pores area (U) in unsorted PDL-, NSP-, and SP-HA disks are 
shown (n = 5). The data are presented as the mean ± SD. *p < 0.01 compared to unsorted PDL and NSP.
Figure 6. Histological analysis of the mineralized matrix in SP-HA disks at 12 weeks after the implantation. Decalcified paraffin-
embedded sections were examined. The sections of SP-HA disks were stained with hematoxylin–eosin (A) and were examined by 
immunohistochemistry for OPN (B), BSP (C), and OCN (D), and by enzyme histochemistry for ALPase (E). Scale bar: 100 mm. 
Arrows in (E) indicate osteoblast-like cells.
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revealed the presence of GFP-positive cells on and in the 
bone-like matrix, suggesting that PDL SP cells directly 
contributed to the matrix formation.
While mesenchymal stem cells in PDL can differen-
tiate into cementoblasts and osteoblasts, it raises a pos-
sibility that the mineralized matrix formed by SP cells 
may be cementum. Cementum contains cementocytes in 
their lacunae as with osteocytes in bone lacunae. Since 
the matrix proteins in cementum and bone tissue are very 
similar, the specific marker to distinguish them has not 
been discovered yet. Thus, it is extremely difficult to solve 
this possibility.
It has been reported that dental pulp-derived SP cells 
form a mineralized matrix in vivo (14). However, this 
matrix contains dentin sialophosphoprotein (14), sug-
gesting that the matrix is a dentin-like but not a bone-like 
one. Thus, dental pulp-derived SP cells are unlikely to 
be a suitable source of cells for bone regeneration. SP 
cells isolated from adipocyte populations have also been 
shown to possess osteogenic potential in vitro and in vivo 
(25,27). Comparison between SP cells originating from 
different tissues needs to be performed in future studies.
It has been argued that the phenotypic differences 
between SP and NSP cells might be caused by Hoechst 
dye-induced damage because it is retained longer in NSP 
cells. In our study, the dye at the concentration (5 mg/ml) 
used for FACS affected neither the proliferation nor dif-
ferentiation of the PDL cells. These results suggest that 
the differences between SP and NSP cells were not attrib-
utable to the toxic effects of Hoechst 33342, although it is 
difficult to completely exclude this possibility.
We found that the ABC transporter MDR-1 was spe-
cifically upregulated in SP cells, suggesting the possibil-
ity that MDR-1 can be used as a marker for SP cells. Since 
it may be possible that Hoechst 33342 exerts cytotoxic 
effects, as mentioned above, MDR-1 could perhaps be a 
better alternative marker to identify SP-like cells.
It has been concerned that the number of the stem cells 
in PDL is limited, and it may not be enough for clinical 
application (18,21,26). Our data that PDL SP cells isolated 
after expansion of cell number by culture for 6 days, com-
prised 2.6% total PDL cells and the proliferation of sorted 
SP cells lower than that of NSP cells, suggest that the prepa-
ration of PDL SP cells is difficult for clinical use. However, 
a ratio of PDL SP cells also did not alter in cultured PDL 
cells for 2 weeks (data not shown). This finding indicates 
that SP cells in a proper environment grow with the same 
proliferative rate to NSP cells. Therefore, the coculture 
system with any cells in PDL as feeder cells might expand 
PDL SP cells. Identification of feeder cells to PDL SP cells 
and osteogenic potentials of PDL SP cells in long-term cul-
ture should be determined in the future.
In conclusion, our results suggest that PDL SP cells 
possessed high osteogenic potential. These cells could 
thus be a potential candidate for a source for cell-based 
regenerative therapy of alveolar bone.
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